CLMT analyst estimates
Calumet (CLMT) analyst ratings, the average price target and its range, and every firm's latest call.
CLMT analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 21, 2026 | Goldman Sachs | Calumet Specialty Products Partners (CLMT) PT Raised to $57 at Goldman Sachs | $57.00 |
| Sep 2, 2026 | H.C. Wainwright | Calumet price target raised to $75 from $60 at H.C. Wainwright | $75.00 |
| Aug 25, 2026 | UBS | Calumet price target raised to $47 from $26 at UBS | $47.00 |
| Aug 18, 2026 | Goldman Sachs | Calumet price target raised to $45 from $40 at Goldman Sachs | $45.00 |
| Jul 30, 2026 | Goldman Sachs | Calumet price target raised to $40 from $36 at Goldman Sachs | $40.00 |
| Apr 24, 2026 | Goldman Sachs | Calumet downgraded to Neutral from Buy at Goldman Sachs | $36.00 |
| Feb 13, 2026 | UBS | Calumet price target raised to $26 from $13.25 at UBS | $26.00 |
| Jan 30, 2026 | Goldman Sachs | Calumet price target raised to $24 from $20 at Goldman Sachs | $24.00 |
| Oct 22, 2025 | Goldman Sachs | Calumet price target raised to $20 from $15 at Goldman Sachs | $20.00 |
| Aug 12, 2025 | UBS | Calumet price target raised to $13.25 from $12 at UBS | $13.25 |
| Mar 5, 2025 | Wells Fargo | Calumet price target lowered to $28 from $29 at Wells Fargo | $28.00 |
| Dec 14, 2022 | UBS | UBS Initiates Coverage On Calumet Specialty with Neutral Rating, Announces Price Target of $15.7 | $15.70 |
| Apr 21, 2022 | Wells Fargo | Wells Fargo Maintains Overweight on Calumet Specialty, Raises Price Target to $29 | $29.00 |
- 4 firms rate CLMT: 1 buy, 3 hold, 0 sell.
- The average price target is $59.67 from 3 analysts, from $47.00 to $75.00.
Updated 2026-11-02 23:11 UTC